Richard Muwonge
Overview
Explore the profile of Richard Muwonge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
3045
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Joshi S, Muwonge R, Bhosale R, Chaudhari P, Kulkarni V, Mandolkar M, et al.
Nat Commun
. 2025 Feb;
16(1):1888.
PMID: 39987163
We report results of a randomized controlled trial to compare 'HPV screen and treat' (Arm 1) and 'HPV screen, triage and treat' (Arm 2) in women living with HIV (WLHIV),...
2.
Bose S, Mandal R, Banerjee D, Vernekar M, Siddiqi M, Chakrabarti J, et al.
Cancer Epidemiol
. 2025 Feb;
95:102776.
PMID: 39970849
Background: Cervical cancer remains a leading cause of cancer related morbidity and mortality among women worldwide, particularly in low-and middle- income countries (LMICs). The incidence of cervical cancer has declined...
3.
Malvi S, Esmy P, Muwonge R, Joshi S, Poli U, Lucas E, et al.
J Natl Cancer Inst Monogr
. 2024 Nov;
2024(67):317-328.
PMID: 39529521
Background: While recommending a human papillomavirus (HPV) single-dose vaccination schedule in 2022, the World Health Organization highlighted the need for long-term follow-up studies to monitor waning of protection. We report...
4.
Mrabti H, Sauvaget C, Bendahhou K, Selmouni F, Muwonge R, Lucas E, et al.
BMC Cancer
. 2024 Jul;
24(1):786.
PMID: 38956536
Background: In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast cancer patients according to their therapeutic management. Methods:...
5.
Basu P, Mwanahamuntu M, Pinder L, Muwonge R, Lucas E, Nyambe N, et al.
Nat Med
. 2024 Jun;
30(9):2596-2604.
PMID: 38918630
Implementing standard-of-care cryotherapy or electrosurgical excision to treat cervical precancers is challenging in resource-limited settings. An affordable technological alternative that is as effective as standard-of-care techniques would greatly improve access...
6.
Selmouni F, Bendahhou K, Sauvaget C, Abahssain H, Lucas E, Muwonge R, et al.
Cancer
. 2024 Jun;
130(19):3353-3363.
PMID: 38837217
Background: This study aimed to indirectly examine whether the implementation of clinical breast examination-based screening program in Morocco has been successful in downstaging and improving survival rates. Breast cancer patients...
7.
Bhatla N, Muwonge R, Malvi S, Joshi S, Poli U, Lucas E, et al.
Hum Vaccin Immunother
. 2023 Dec;
19(3):2289242.
PMID: 38078840
Long-term follow-up of a cohort of unmarried girls who received one, two, or three doses of quadrivalent HPV vaccine, between 10 and 18 years of age, in an Indian multi-centric...
8.
Sharma H, Parekh S, Pujari P, Shewale S, Desai S, Bhatla N, et al.
Lancet Oncol
. 2023 Nov;
24(12):1321-1333.
PMID: 37949086
Background: To meet global cervical cancer elimination efforts, a wider range of affordable and accessible vaccines against human papillomavirus (HPV) are needed. We aimed to evaluate the immunogenicity and safety...
9.
M de Carvalho T, Man I, Georges D, Saraswati L, Bhandari P, Kataria I, et al.
BMJ Glob Health
. 2023 Nov;
8(11).
PMID: 37931940
Background: Cervical cancer is a major public health problem in India, where access to prevention programmes is low. The WHO-Strategic Advisory Group of Experts recently updated their recommendation for human...
10.
Ibrahim Khalil A, Zhang L, Muwonge R, Sauvaget C, Basu P
BMJ Open
. 2023 Oct;
13(10):e069616.
PMID: 37879679
Objectives: We aim to assess the efficacy and safety of therapeutic human papillomavirus (HPV) vaccines to treat cervical intraepithelial neoplasia of grade 2 or 3 (CIN 2/3). Design: Systematic review...